carbon monoxide has been researched along with Hypertrophy, Left Ventricular in 1 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
Hypertrophy, Left Ventricular: Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ritchie, RH | 1 |
| Irvine, JC | 1 |
| Rosenkranz, AC | 1 |
| Patel, R | 1 |
| Wendt, IR | 1 |
| Horowitz, JD | 1 |
| Kemp-Harper, BK | 1 |
1 review available for carbon monoxide and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Exploiting cGMP-based therapies for the prevention of left ventricular hypertrophy: NO* and beyond.
Topics: Carbon Monoxide; Cardiovascular System; Cyclic GMP; Guanylate Cyclase; Humans; Hypertrophy, Left Ven | 2009 |